Evaluation of Electric Wheelchair Driving Performance in Simulator Compared to Driving in Real-life Situations (SIMADAPT1)

January 30, 2020 updated by: Pôle Saint Hélier

Evaluation of Electric Wheelchair Driving Performance in Simulator Compared to Driving in a Real-life Situation, in a Population of Regular Drivers With Neurological Disorders

The device that is the subject of this investigation is a solution for driving simulation of an electric wheelchair. It is intended to enable patients who are likely to acquire an electric wheelchair to train in a virtual environment, favorable to the safety of training, to its repetition, and to produce more varied, rich training environments and more tailored to specific and individualized needs. These solutions will make it easier to access real-world driving for patients who are currently experiencing learning difficulties.

It is expected that this investigation demonstrates the reproducibility of driving performance in electric wheelchair driving simulator compared to the real world.

Study Overview

Detailed Description

As part of this investigation, it is expected to develop a driving simulator that could contribute to improving the learning of electric wheelchair driving and access to electric wheelchair for people who can not currently claim for physical risks and weak psychology for the participant in the research.

The present clinical investigation aims at evaluating the performances, the safety and the satisfaction of the users with regard to a simulator of driving of electric wheelchair in virtual reality.

The main objective is to evaluate the feasibility of a virtual electric wheelchair driving training, comparing driving performance in virtual reality versus reality, in identical real and virtual standardized circuits, in regular users of electric wheelchairs with neurological disorders.

Study Type

Interventional

Enrollment (Actual)

31

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Bretagne
      • Rennes, Bretagne, France, 35000
        • Pôle Saint-Hélier

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Male or female, over 18 years old,
  • Having freely consented to participate in the study,
  • With neurological degenerative disorders including cerebrovascular accident and head trauma or neurodegeneration including Parkinson's disease and related syndromes, multiple sclerosis, myopathy and amyotrophic lateral sclerosis,
  • Having benefited from an electric wheelchair prescription and traveling in electric wheelchair for more than 3 months,
  • Whose electric wheelchair is the main mode of travel,
  • The physical measurements (weight, size) are compatible with the use of the physical simulator chosen for the development of the robotic assistance module, according to manufacturer's data 140 kg max and 51 cm max of seat width .

Exclusion Criteria:

  • Understanding difficulties preventing the realization of the protocol,
  • Motor disorders of the upper limb requiring additional driving technical assistance,
  • Patient having expressed difficulties impacting his safety of sedan and / or external, objectified by a negative answer to more than one item on the self-questionnaire WST QF for the items pertaining to driving (6 to 12 and 17 to 28):

    1. inability to perform certain driving tasks (answer "no")
    2. or insecure to achieve them (answer "not at all").
  • pregnant, parturient or nursing mother,
  • Person deprived of liberty by a judicial or administrative decision, persons under psychiatric care or admitted to a health or social institution for purposes other than research,
  • Minor,
  • Major under legal protection or unable to express his consent,
  • Person in emergency situation who can not express their prior consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
OTHER: Driving an electric wheelchair in real condition
In order to be able to evaluate the feasibility of virtual reality driving training, the driving performance will be evaluated on the same 3 standardized circuits: for the control group, 3 circuits of test of pipes in real condition of increasing difficulty are tested. Patients perform 2 passes in this condition.
For the control group, 3 test circuits of pipes in real condition of increasing difficulty are tested. Patients perform 2 passes in this condition.
EXPERIMENTAL: Driving an electric wheelchair in virtual condition
In order to be able to evaluate the feasibility of driving training in virtual reality, the driving performance will be evaluated on the same 3 standardized circuits: for the virtual reality group, the circuits have been digitized. Patients perform 2 passes in this condition.
For the virtual reality group, the circuits have been digitized. Patients perform 2 passes in this condition.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of collision
Time Frame: Day 1
The primary judgment criterion is the number of collisions on different standardized circuits in real condition versus virtual condition
Day 1
Number of collision
Time Frame: Day 8
The primary judgment criterion is the number of collisions on different standardized circuits in real condition versus virtual condition
Day 8
Number of collision
Time Frame: Day 15
The primary judgment criterion is the number of collisions on different standardized circuits in real condition versus virtual condition
Day 15

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Driving Speed
Time Frame: Day 1, Day 8 and Day 15
Speed measured by the completion time of the course on the different circuits in real condition versus virtual condition
Day 1, Day 8 and Day 15
Wheelchair Skill Test (WST)
Time Frame: Day 1, Day 8 and Day 15
Driving performance measured by the Wheelchair Skill Test items corresponding to the different courses in real condition versus virtual condition
Day 1, Day 8 and Day 15
NASA-Task Load Index
Time Frame: Day 1, Day 8 and Day 15
The cognitive load of tests under both conditions will be measured by the NASA-Task Load Index. It is in the form of six scales where the participant must assign a score between zero and one hundred to each of them, score indicating a growing level of intensity. Three dimensions relate to the demands imposed on the subject (mental, physical and temporal demands) and three to the interaction of a subject with the task (effort, frustration and performance)
Day 1, Day 8 and Day 15
Ease of Use Questionnaire
Time Frame: Day 1, Day 8 and Day 15
The satisfaction of the use of the electric wheelchair under the conditions will be evaluated by the self-questionnaire Ease of Use Questionnaire. It measures the subjective usability of a product or service. It is a 30-item survey that examines four dimensions of usability: usefulness, ease of use, ease of learning, and satisfaction. The questionnaires were constructed as seven-point Likert rating scales. Users were asked to rate agreement with the statements, ranging from strongly disagree (1) to strongly agree (7).
Day 1, Day 8 and Day 15
Unified theory of acceptance of technology questionnaire (UTAUT)
Time Frame: Day 1, Day 8 and Day 15
Questionnaire of acceptability / acceptance of the tool and its use by patients based on the Unified Theory of Acceptance and Use Technology (UTAUT).
Day 1, Day 8 and Day 15
Igroup Presence Questionnaire (IPQ)
Time Frame: Day 1, Day 8 and Day 15
The IPQ comprises 14 items rated on a seven-point Likert Scale ranging from -3 to 3. The general item assesses the general "sense of being there", and has high loadings on all three factors, with an especially strong loading on Spatial Presence. The Spatial Presence sub-scale is related to the sense of being physically inside the virtual environment. The involvement sub-scale is directed to evaluate the attention devoted to the virtual environment. The realness sub-scale evaluates the sense of reality attributed to the virtual environment.
Day 1, Day 8 and Day 15
The learning effect
Time Frame: Day 1, Day 8 and Day 15
The learning effect on the virtual circuit and on the real circuit, will be evaluated by progression / stabilization of the time of realization during the sequence of repetitions.
Day 1, Day 8 and Day 15
Graybiel score
Time Frame: Day 1, Day 8 and Day 15
Assessment of discomfort and motion sickness to quantify the intensity of different symptoms during motion sickness.
Day 1, Day 8 and Day 15

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 14, 2020

Primary Completion (ACTUAL)

January 29, 2020

Study Completion (ACTUAL)

January 29, 2020

Study Registration Dates

First Submitted

November 19, 2019

First Submitted That Met QC Criteria

November 19, 2019

First Posted (ACTUAL)

November 21, 2019

Study Record Updates

Last Update Posted (ACTUAL)

January 31, 2020

Last Update Submitted That Met QC Criteria

January 30, 2020

Last Verified

November 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2019-A01903-54

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neurologic Disorder

Clinical Trials on Driving an electric wheelchair in real condition

3
Subscribe